S
Silence Therapeutics Plc D
D
SLN
6.04600
USD
0.25
(4.24%)
مغلق
حجم التداول
3,941
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
285,554,291
العنوان: Silence Therapeutics Plc
القطاع: Healthcare
الصناعة: Biotechnology
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.